Efficacy of dyslipidaemia management before and after intervention stratified by sex
| Characteristic | Preintervention (n=896) | Postintervention (n=862) | P value |
| Male | (n=398) | (n=382) | |
| Eligible for statins | 211(53) | 229 (59.9) | 0.051 |
| Reasonable management* | 333 (83.7) | 324 (84.8) | 0.660 |
| Overtreatment | 22 (5.5) | 17 (4.5) | 0.49 |
| Undertreatment | 43 (10.8) | 41 (10.7) | 0.974 |
| Female | (n=498) | (n=480) | |
| Eligible for statins | 179 (35.9) | 182 (37.9) | 0.523 |
| Reasonable management* | 419 (84.1) | 439 (91.5) | <0.0001 |
| Overtreatment | 51 (10.2) | 23 (4.8) | 0.001 |
| Undertreatment | 28 (5.6) | 18 (3.8) | 0.167 |
| Males eligible for statins | (n=211) | (n=229) | |
| On statins | 168 (79.6) | 188 (82.1) | 0.509 |
| On target | 108 (51.2) | 144 (62.9) | 0.013 |
| Females eligible for statins | (n=179) | (n=182) | |
| On statins | 151 (84.4) | 164 (90.1) | 0.101 |
| On target | 107 (59.8) | 123 (67.6) | 0.123 |
*Reasonable management means patients on statins who were eligible for this therapy or patients not on statins who were not eligible.